ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon gets CDSCO nod for generic diabetes medication
Biocon has secured Indian regulatory approval for its generic Liraglutide drug substance and product, a version of Victoza, for treating Type 2 Diabetes in adults and children over 10. CEO Siddharth Mittal highlighted the importance of this vertically inte
Announcement as on 03 June 2025

Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw
Biocon is planning a ₹4,500 crore fundraise to increase promoter stake in Biocon Biologics and convert structured venture debt into equity, aiming to improve profitability. The company is also considering a merger with its parent company as an alternativ
Announcement as on 15 May 2025

Biocon plans 0-million capex in two years
Biocon plans a 0 million capital expenditure, allocating 0 million to biologics, primarily enhancing Malaysian capacities, and million to generics. Fueled by strong generics growth and biosimilar progress, Q4 net profit surged 153%. The company l
Announcement as on 10 May 2025

Biocon Biologics secures multiple market access agreements in US for Yesintek
Biocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Multiple formularies, including Express Scripts, Cigna, and UnitedHealthcare, will include Yesintek starting in 2025. Thi
Announcement as on 05 May 2025

Biocon Biologics secures market entry for Yesafili in US
Biocon Biologics has reached a settlement and licensing agreement with Regeneron, clearing the way for the US commercialization of Yesafili, its biosimilar to Eylea. The agreement allows Biocon Biologics to launch Yesafili in the US by the second half of 2
Announcement as on 15 April 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 377.68
  • 12Day Average: 384.77
  • 20Day Average: 386.47
  • 50Day Average: 378.38
  • 100Day Average: 384.98
  • 150Day Average: 375.54
  • 200Day Average: 373.22

532523 Indicators & signals

Indicator MACD (12,26,9)

382.39, 382.83, 1.89
Indicator MACD is in negative zone

Indicator ADX (14)

24.05, 18.34, 29.95
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
19 Thu Mar 2026 368.35 366.45 to 379.40 -3.65% 0.22 times
18 Wed Mar 2026 382.30 376.90 to 386.00 1.19% 0.49 times
17 Tue Mar 2026 377.80 375.20 to 382.80 0.28% 0.49 times
16 Mon Mar 2026 376.75 369.20 to 387.40 -1.68% 0.81 times
13 Fri Mar 2026 383.20 382.35 to 398.65 -2.42% 3.65 times
12 Thu Mar 2026 392.70 388.80 to 397.30 -0.67% 0.47 times
11 Wed Mar 2026 395.35 394.45 to 402.75 -0.08% 0.9 times
10 Tue Mar 2026 395.65 393.20 to 398.45 1.5% 1.21 times
09 Mon Mar 2026 389.80 379.35 to 390.90 -0.17% 0.41 times
06 Fri Mar 2026 390.45 386.60 to 394.20 1% 0.51 times
05 Thu Mar 2026 386.60 379.15 to 389.00 2.21% 1.05 times
04 Wed Mar 2026 378.25 375.70 to 385.30 -2.6% 14.97 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top